AbbVie Inc.

NYSE: ABBV · Real-Time Price · USD
204.72
3.25 (1.61%)
At close: Aug 14, 2025, 3:59 PM
205.30
0.28%
Pre-market: Aug 15, 2025, 07:20 AM EDT

AbbVie Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
56.33B 54.32B 58.05B 56.2B
Cost of Revenue
16.9B 20.41B 17.41B 17.45B
Gross Profit
39.43B 33.9B 40.64B 38.75B
Operating Income
9.14B 12.76B 18.12B 17.92B
Interest Income
648M 540M 186M 39M
Pretax Income
3.72B 6.25B 13.48B 12.99B
Net Income
4.28B 4.86B 11.84B 11.54B
Selling & General & Admin
13.19B 12.87B 15.26B 12.35B
Research & Development
12.79B 7.67B 6.51B 8.05B
Other Expenses
4.31B 599M 753M 432M
Operating Expenses
30.29B 21.15B 22.52B 20.83B
Interest Expense
2.81B 2.22B 2.23B 2.42B
Selling & Marketing Expenses
2.1B n/a 2B 2.1B
Cost & Expenses
47.2B 41.56B 39.94B 38.27B
Income Tax Expense
-570M 1.38B 1.63B 1.44B
Shares Outstanding (Basic)
1.77B 1.77B 1.77B 1.77B
Shares Outstanding (Diluted)
1.77B 1.77B 1.78B 1.78B
EPS (Basic)
2.40 2.73 6.65 6.48
EPS (Diluted)
2.39 2.72 6.63 6.45
EBITDA
14.91B 17.17B 24.17B 23.93B
EBIT
6.52B 8.47B 15.71B 15.41B
Depreciation & Amortization
8.39B 8.7B 8.47B 8.52B